Profile
Penny S.
Toren worked as a Senior VP-Regulatory Affairs & Program Management at Vallon Pharmaceuticals, Inc. from 2018 to 2022.
She completed her undergraduate degree at Florida Atlantic University and her graduate degree at New York Medical College.
Former positions of Penny S. Toren
| Companies | Position | End |
|---|---|---|
| GRI BIOPAR | General Counsel | 19/04/2022 |
Training of Penny S. Toren
| Florida Atlantic University | Undergraduate Degree |
| New York Medical College | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Penny S. Toren
